Canadian Investment Regulatory Organization Trade Resumption - CRDL

Canadian Investment Regulatory Organization Trade Resumption - CRDL

Trading resumes in:

Company: Cardiol Therapeutics Inc.

TSX Symbol: CRDL

All Issues: Yes

Resumption (ET): 8:00 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada..

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

Cision View original content: http://www.newswire.ca/en/releases/archive/October2025/20/c1710.html

News Provided by Canada Newswire via QuoteMedia

crdl:catsx:crdlbiotech investing
CRDL:CA
The Conversation (0)
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Bioscience:  Drug Delivery Platform Innovator with Multiple Mainstream Applications

Keep Reading...
Lexaria Bioscience

Lexaria Bioscience

Keep Reading...
A pile of white round GLP-1 tablets on a blue surface.

Rewriting the Patient Journey: GLP‑1 Drugs and the Rise of Oral Therapies

Weight loss drugs continue to play out in the global market, with forecasts estimated at a value of US$200 billion by 2030.Leading the rise are oral GLP-1 drugs, with new obesity pills projected to push the GLP-1 market into its next chapter in 2026. The demand is perpendicular to rising obesity... Keep Reading...
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

600,000 New Wegovy® Pill Prescriptions Written in First Two Months KELOWNA, BC / ACCESS Newswire / April 21, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this update of additional recent developments in the... Keep Reading...
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Triple ISO Certification Recognition Positions Company as a Standard-Bearer in Clinical Decision Support Quality Infrastructure

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced that Seegnal eHealth Ltd., its Israeli operating subsidiary, has been granted the prestigious Gold Mark by the... Keep Reading...
Lexaria Bioscience Corp. (Nasdaq: LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Lexaria Bioscience Corp. (Nasdaq: LEXX), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the engagement of the contract research organization (“CRO”) to execute and report on its 2026 animal Study #1 (GLP-1-A26-1) that will evaluate a number of... Keep Reading...

Latest News

Interactive Chart

Latest Press Releases

Aterian PLC: Africa-focused Critical Minerals Exploration Company

Results of Meeting

Valeura Charters the Enterprise Drilling Rig

GoldInxs Mining: Early-stage Exposure to Copper-Gold in British Columbia

Related News

gold investing

Aterian PLC: Africa-focused Critical Minerals Exploration Company

aluminum investing

Results of Meeting

oil and gas investing

Valeura Charters the Enterprise Drilling Rig

gold investing

GoldInxs Mining: Early-stage Exposure to Copper-Gold in British Columbia

energy investing

American Uranium Entitlement Offer Update

uranium investing

Trading Halt

aluminum investing

Ore Reserves and Mineral Resources Update